Misidentification of SMMC-7721 undermines its use as a hepatocellular carcinoma model

Ralf Weiskirchen

Open source

DOI
10.1007/s00210-026-05868-8
Published
2026-09-01
Container
Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05868-8,
  title = {Misidentification of SMMC-7721 undermines its use as a hepatocellular carcinoma model},
  author = {Ralf Weiskirchen},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-05868-8},
  url = {https://doi.org/10.1007/s00210-026-05868-8}
}

RIS

TY  - JOUR
TI  - Misidentification of SMMC-7721 undermines its use as a hepatocellular carcinoma model
AU  - Ralf Weiskirchen
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-05868-8
UR  - https://doi.org/10.1007/s00210-026-05868-8
ER  - 

APA

Weiskirchen, R. (2026). Misidentification of SMMC-7721 undermines its use as a hepatocellular carcinoma model. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05868-8

Source records